Episode Chapters
- Is Aspirin Dead in A-Fib?12:14Paper Chase #1 | Solid Fuel Use and Mortality in China6:27Annual Physical: Friend or FoeFree Chapter23:16PTSD and Trauma Related Disorders | Part 116:38Paper Chase #2 | Wait Time and Mortality in Hip Fracture Surgery4:27IV Fluid Selection, Part II16:17PTSD and Trauma Related Disorders | Part 216:14Paper Chase #3 | CV Safety of Febuxostat5:14Preconception Counseling21:35Leaving AMA15:40Paper Chase #4 | A1c Target Guidelines4:32Hemoptysis22:28Paper Chase #5 | Varicose Veins, VTE and PAD2:56The Summary20:45
In this PC RAP family reunion, Rob Orman and Neda Frayha discuss the latest evidence on the use of aspirin in low-risk a-fib (CHA2DS2-VASc score of 0 or 1).
All Risk, No Reward Full episode audio for MD edition 187:18 min - 88 MB - M4AHippo PC RAP July 2018 Written Summary 362 KB - PDF
Ian L., Dr - August 28, 2018 3:54 PM
Aspirin might be of low efficacy but the LEGACY trial the long term effect of weight loss in atrial fibrillation by Pathak RK et al showed a six fold reduction in "arrhythmia free survival " in patients who sustained a 10% of body weight over one year.